2020
DOI: 10.1016/j.medj.2020.06.008
|View full text |Cite
|
Sign up to set email alerts
|

Investigating Ketone Bodies as Immunometabolic Countermeasures against Respiratory Viral Infections

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
46
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
10

Relationship

1
9

Authors

Journals

citations
Cited by 52 publications
(61 citation statements)
references
References 245 publications
(362 reference statements)
0
46
0
Order By: Relevance
“…According to the conclusions of a recent review, ketone bodies are endogenous metabolites involved in cellular energy homeostasis, but they also have important signaling activities that affect immunological activity. Therefore, knowledge regarding the role of ketone bodies in the fight against respiratory viral infections and the development of intervention studies based on the administration of exogenous ketone bodies as new immunometabolic therapies for these diseases could offer potential resources to deal with the SARS-CoV-2 pandemic [165]. Finally, due to the continuous production of scientific evidence and the results of the first clinical trials, it cannot be ruled out that other compounds must also be considered as potential strengtheners of the immune system, and other elements beyond genetics must be taken into account as factors that require less bioavailability of these essential nutrients.…”
Section: Discussionmentioning
confidence: 99%
“…According to the conclusions of a recent review, ketone bodies are endogenous metabolites involved in cellular energy homeostasis, but they also have important signaling activities that affect immunological activity. Therefore, knowledge regarding the role of ketone bodies in the fight against respiratory viral infections and the development of intervention studies based on the administration of exogenous ketone bodies as new immunometabolic therapies for these diseases could offer potential resources to deal with the SARS-CoV-2 pandemic [165]. Finally, due to the continuous production of scientific evidence and the results of the first clinical trials, it cannot be ruled out that other compounds must also be considered as potential strengtheners of the immune system, and other elements beyond genetics must be taken into account as factors that require less bioavailability of these essential nutrients.…”
Section: Discussionmentioning
confidence: 99%
“…However, therapies that increase R-BHB levels, including the consumption of a ketogenic diet or different forms of exogenous ketones, will be the focus of this review. Others have also suggested that increasing systemic ketone levels may aid host defenses against respiratory viral infection, in part, by decreasing inflammation [ 1 , 2 ], including a recent comprehensive review [ 3 ], while a clinical trial of the effects of a ketogenic diet on intubated SARS-CoV-2 patients has recently been registered ( NCT04358835 ).…”
Section: Introductionmentioning
confidence: 99%
“…Studies have shown that a KD reduces circulating inflammatory markers in humans [26] . The KD, via hydroxybutyrate (HB), is capable of activating hydroxycarboxylic acid receptor 2 (HCA2), a G protein-coupled receptor, which inhibits NF-kB in macrophages, dendritic cells and microglia and reduces neuroinflammation [27] .…”
Section: Discussionmentioning
confidence: 99%